Liriodendrin alleviates endometriosis via PPARγ activation and inhibition of NLRP3 inflammasome-mediated pyroptosis

Zhang S, Sijia Zhang, Yang Y, Yi Yang, Xiaoyao Chen, Chen X, Liu X, Xiangtong Liu, Wang Y, Yicheng Wang, Li J, Jiaoyue Li, Wang H, Huan Wang, Changming Zhai, Zhai C, Li D, Dihua Li, Xiaona Ma, Ma X
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026 · vol. 162 , pp. 158808 · doi:10.1016/j.phymed.2026.158808 · PMID:42771953 · W7213294861
Lab / animal OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-18 ⓘ

Liriodendrin alleviates endometriosis by activating PPARγ and inhibiting NLRP3 inflammasome-mediated pyroptosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Excessive activation of inflammatory responses and oxidative stress plays a critical role in the pathophysiology of endometriosis (EMs), which is characterized by ectopic lesion growth and chronic pelvic pain. However, effective non-hormonal therapies targeting these processes remain limited. PURPOSE: To investigate the inhibitory effects of Liriodendrin (LIR) on EMs progression and elucidate its underlying mechanisms. STUDY DESIGN: An integrative experimental study combining in vivo, in vitro, transcriptomic, and mechanistic analyses. METHODS: An EMs mouse model was established via intraperitoneal implantation of endometrial fragments. Lesion size, weight, histopathology, and pain-related markers were assessed. Transcriptomic profiling combined with LASSO regression and protein-protein interaction (PPI) network analysis was used to identify key targets. Cellular thermal shift assays (CETSA), SPR and molecular dynamics simulations were used to assess LIR-protein interactions. PPARγ knockdown, along with agonist and antagonist interventions, was performed to determine pathway dependence. Oxidative stress and pyroptosis were evaluated by measuring ROS levels, NRF2/HO-1 signaling, and pyroptosis-related markers (NLRP3, GSDMD, IL-1β, IL-18) using Western blot, RT-qPCR, and fluorescence staining. RESULTS: LIR significantly inhibited ectopic lesion growth and attenuated thermal hyperalgesia, accompanied by reduced expression of the nociceptive markers NGF, TRPV1, CGRP, and IB4. Mechanistically, LIR activated the PPARγ/RXRα/NRF2 antioxidant pathway and attenuation of oxidative stress. LIR suppressed NLRP3 inflammasome activation and GSDMD-mediated pyroptosis, accompanied by reduced secretion of IL-1β and IL-18. CONCLUSION: LIR alleviates EMs progression through modulation of PPARγ-associated antioxidant signaling and attenuation of NLRP3-associated pyroptotic activation, highlighting its potential as a non-hormonal therapeutic candidate.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

SciLite annotations

chemicals 2
rhododendrin rhododendrin
organisms 1
transgenic mice

Source provenance

europepmc
last seen: 2026-11-06T06:14:58.568748+00:00
openalex
last seen: 2026-11-06T06:06:51.996266+00:00
pubmed
last seen: 2026-11-06T06:08:30.426793+00:00
scilite
last seen: 2026-09-27T09:57:59.810255+00:00
unpaywall
last seen: 2026-11-06T06:34:47.334260+00:00
License: CC0 · commercial use OK